Despite interest in biotechnology by Venezuelan researchers and farmers to meet growing food demand and protect the environment, there is no commercial adoption, as the lack of implementing regulations hinders real technological progress and trade.
THIS REPORT CONTAINS ASSESSMENTS OF COMMODITY AND TRADE ISSUES MADE BY
USDA STAFF AND NOT NECESSARILY STATEMENTS OF OFFICIAL U.S. GOVERNMENT
Required Report - public distribution
GAIN Report Number: VE1154
Agricultural Biotechnology Annual
Interest expressed by farmers and research being done by scientists to improve agricultural output
and the environment via biotechnology has not resulted in a legal framework for either testing or
commercialization, holding down domestic output and import potential. Most research done
involves tissue cultures or molecular genetics. Most projects have been halted since 2006 and no
change in this situation is expected in the short term.
Section I. Executive Summary:
Despite interest in biotechnology by Venezuelan researchers and farmers to meet growing food
demand and protect the environment, there is no commercial adoption, as the lack of
implementing regulations hinders real technological progress and trade. A fairly extensive list of
international treaties and domestic laws provide a potential basic legal framework for agricultural
biotechnology, but the regulatory system is imprecise.
Section II. Plant Biotechnology Trade and Production:
There are no commercial biotechnology crops under development in Venezuela, and the Bolivarian
Republic of Venezuela (BRV) has not granted approval for planting biotechnology crops from any
source. There is significant interest by research centers and universities in developing
biotechnology. The majority of biotechnology research is in fact molecular genetics and tissue
culture, as well as diagnostics of animal viral diseases. The research is mainly done by government
institutions and universities, with minimal private sector involvement.
Section III. Plant Biotechnology Policy:
Agricultural biotechnology is the responsibility of Venezuela?s Ministry of Environment and Natural
Resources (MARN). MARN?s ?Dirección de Bioseguridad y Biocomercio? is in charge of
administering and regulating genetic resources, biotechnology security, and encouraging related
activities that enhance the use of biodiversity. Among the specific functions of this office are:
Evaluate all issues related to biotechnology security as well as traditional knowledge
associated to biological diversity
Coordinate activities of the access committee of genetic resources.
Issue genetic resource access contracts
As noted above, work done in Venezuela to date is not specifically gene insertion or modifications,
as there are no laws that permit it.
Section IV. Plant Biotechnology Marketing Issues:
Despite the government?s reluctance to allow marketing or development of biotech, Venezuelan
producers continue to express their need for and acceptance of biotech products. The Federation
of Agricultural Producers forecasts that domestic production could double in two years if the
regulatory framework for biotech would establish the free use of biotech seeds. Other producer
groups have criticized the government for not allowing the use of agricultural biotechnology to the
detriment of domestic production. Consumers have not voiced any significant concerns about
biotechnology or products containing biotechnology raw materials.
Section V. Plant Biotechnology Capacity Building and Outreach:
There are no U.S. government funded capacity building or outreach activities conducted in
Venezuela that relate to agricultural biotechnology. In 2005, the United Nations Environmental
Program allocated funds to increase public awareness of agricultural biotech and have a consensus
among the public and private sector regarding the national biotechnology framework.
Section VI. Animal Biotechnology:
There are no animal biotechnology events under development in Venezuela, and the government
has not granted approval for animal biotechnology from any source. There is significant interest
by research centers and universities in developing biotechnology.
The use of animal biotechnology techniques is less developed; use has been restricted almost
exclusively to the diagnosis of diseases, mainly viral in nature. To date, the information obtained
has been based on vaccine produced abroad, not domestically.
Section VII. Author Defined:
International Regulations Related To Biological Diversity, Subscribed And Approved By
? Convention for the Protection of Flora, Fauna and Natural Scenic Beauties of America (October
12th, 1940, Washington D.C., United States).
? Convention concerning Wetlands of International Importance Especially as Habitat of Aquatic
(February 2nd, 1971 Ramsar, Iran).
? Biodiversity Agreement. Plant Variety (Cartagena Agreement), Decision, 21/10/1993, No. 345.
Common Provisions on the Protection of the Rights of Breeders of New Plant Varieties